The abstract is read at the publisher; the summary is JClub's.
Macrophage-specific transketolase (TKT) loss in diabetic wounds accelerates catabolism, raises reactive oxygen species, and disrupts endothelial proliferation and differentiation, impairing angiogenesis.
- Why it matters: Impaired diabetic wound healing is linked to macrophage metabolic dysfunction that compromises vascular regeneration, but the metabolic checkpoint controlling angiogenesis is unclear.
- What they did: The study shows hyperglycemia suppresses macrophage TKT via an AGEs-RAGE signaling cascade, forming a pathological TKT-AGEs-RAGE axis; it then tests a nanozyme-integrated hydrogel patch that increases macrophage TKT.
- The result: Restoring TKT rebalances macrophage metabolism, lowers oxidative stress, and rescues angiogenic capacity, and localized nano-system delivery in a diabetic pig model markedly accelerates wound closure and vascular repair.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.